v3.26.1
Segment and Geographic Information - Segment Reporting (Details) - USD ($)
$ in Millions
 3 Months Ended
Jul. 31, 2026
Jul. 25, 2025
Segment Reporting [Line Items]    
Net sales $ 9,756 $ 8,578
Cost of products sold, excluding amortization of intangible assets 3,416 3,001
Research and development expense 771 726
Selling, general, and administrative expense 3,198 2,806
Reportable segment operating profit 1,764 1,445
Other non-operating expense (income), net 190 33
Amortization of intangible assets (412) (459)
Certain litigation charges, net 0 (27)
Income before income taxes 1,769 1,302
Operating Segments    
Segment Reporting [Line Items]    
Net sales 8,884 7,785
Cost of products sold, excluding amortization of intangible assets 3,013 2,668
Research and development expense 656 606
Selling, general, and administrative expense 2,872 2,497
Other segment items 32 (12)
Reportable segment operating profit 2,311 2,027
Segment reconciling items    
Segment Reporting [Line Items]    
Other adjustments   39
Currency and other (69) (47)
Interest expense, net (186) (176)
Other non-operating expense (income), net 190 33
Amortization of intangible assets (412) (459)
Restructuring and associated costs (89) (67)
Acquisition and divestiture-related items (50) (58)
Certain litigation charges, net   (27)
Cardiovascular | Operating Segments    
Segment Reporting [Line Items]    
Net sales 3,927 3,285
Cost of products sold, excluding amortization of intangible assets 1,308 1,132
Research and development expense 303 280
Selling, general, and administrative expense 1,269 1,060
Other segment items 14 (15)
Reportable segment operating profit 1,033 828
Neuroscience | Operating Segments    
Segment Reporting [Line Items]    
Net sales 2,678 2,427
Cost of products sold, excluding amortization of intangible assets 786 724
Research and development expense 163 157
Selling, general, and administrative expense 922 831
Other segment items 13 2
Reportable segment operating profit 793 713
Medical Surgical | Operating Segments    
Segment Reporting [Line Items]    
Net sales 2,279 2,073
Cost of products sold, excluding amortization of intangible assets 919 812
Research and development expense 189 169
Selling, general, and administrative expense 681 605
Other segment items 5 1
Reportable segment operating profit 485 486
Diabetes | Operating Segments    
Segment Reporting [Line Items]    
Net sales 843 721
Other Operating Segments | Operating Segments    
Segment Reporting [Line Items]    
Other adjustments   39
Other Operating Segments, Including Diabetes | Operating Segments    
Segment Reporting [Line Items]    
Net sales 872 755
Reportable segment operating profit $ 74 $ 37